PrEP on the go: study shows promise in delivering HIV prevention at syringe programs
NCT ID NCT04782180
First seen Dec 31, 2025 · Last updated Jun 05, 2026 · Updated 29 times
Summary
This study tested whether giving HIV prevention medicine (PrEP) right away at a syringe services program helps people stay HIV-negative. 90 adults who were already enrolled in the program and tested negative for HIV took part. Researchers measured how much of the medicine was in their blood after 6 months to check if they were taking it regularly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.